M&A Deal Summary

Biocompare Acquires Chromocyte

On November 23, 2021, Biocompare acquired internet software and services company Chromocyte

Acquisition Highlights
  • This is Biocompare’s 1st transaction in the Internet Software and Services sector.
  • This is Biocompare’s 1st transaction in the United Kingdom.

M&A Deal Summary

Date 2021-11-23
Target Chromocyte
Sector Internet Software and Services
Buyer(s) Biocompare
Deal Type Add-on Acquisition

Target

Chromocyte

Sheffield, United Kingdom
Chromocyte is an impartial and innovative online resource for designing complex multi-parameter flow cytometry antibody panels and finding the reagents and antibodies that are required for these and other related techniques. Chromocyte was founded in 2009 and is based in Sheffield, England.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Biocompare

South San Francisco, California, United States

Category Company
Founded 2000
Sector Internet Software and Services
DESCRIPTION

Biocompare is a resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative resource that enables them to make a better product, technology, and service purchasing decisions. Biocompare was founded in 2000 and is based in South San Francisco, California.


DEAL STATS #
Overall 1 of 1
Sector: Internet Software and Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: United Kingdom M&A 1 of 1
Year: 2021 M&A 1 of 1